Belmora has petitioned the Fourth Circuit to reconsider its decision that Bayer did not need to use the Flanax mark in the US to sue under the Lanham Act. Belmora says the court “appeared to be motivated by a sense of ethical outrage”
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Rebecca Newman at Addleshaw Goddard, who live-reported on the seminal dispute, unpicks the trials and tribulations of the case and considers its impact
IP leaders at Brandsmiths and Bird & Bird, who were on opposing sides at the UK Supreme Court in Iconix v Dream Pairs, unpick the landmark case and its ramifications